GoPubMed Wins the 2009 Red Dot: Best of the Best Award for Excellence in Communication Design

Transinsight's GoPubMed.com, the semantic search engine for the life sciences, has been recognized with the 2009 red dot: best of the best award in the category communication design - graphical user interfaces and interactive tool. A total of 6,112 submissions were received from 42 countries.

The jury selected 470 entries for the "red dot design award". A group of only 56 submissions were selected as "the best of the best" and will be participating in the final round for the "grand prix award". The Transinsight team is proud to receive this prestigious award.

The upcoming challenges in the area of the semantic web are mainly related to user interaction. Fostering communication between humans and large scale data volumes beyond today's key word search is of great importance to make data, information and knowledge manageable.

The design philosophy behind GoPubMed.com is strictly aligned with this overall principle: knowledge- and meaning-based computing. The brain-like use of a knowledge network of more than 15 million concepts and half a billion of documents brings up extremely difficult issues when it comes to dealing with these overwhelming amounts of data. For the first time, this was achieved with the technology used in the novel semantic search engine. It is a great satisfaction that this innovation in communication design was recognized by a distinguished international team of reviewers.

"For us, this award shows recognition of our design competence and quality as well as an outstanding confirmation of our performance when it comes to the development of leading edge technology for information-heavy tasks. In the field of semantic search, acceptance by users is of utmost importance, since people in 'real life' were not made for dealing with billions of data in the critical decision making process," said Dr. Michael R. Alvers, CEO of Transinsight. "The entire team - technicians and designers - enjoy this show of appreciation for their three years of hard work. I thank team members for this outstanding achievement," he continued. GoPubMed.com is free of charge for non-commercial use.

About Transinsight
Transinsight is focused on semantic software solutions in the area of knowledge- and meaning-based computing. The flagship product, GoPubMed PRO, a semantic biomedical search engine, is the first knowledge-based search engine for the Life Sciences on the Internet. The enterprise is headquartered in Dresden, Germany. Transinsight is ranked under the Top 5 biotech companies in Europe. For further information, visit http://www.transinsight.com.

Most Popular Now

Pfizer's elranatamab granted FDA Breakthrough Ther…

Pfizer Inc. (NYSE:PFE) announced its investigational cancer immunotherapy, elranatamab, received Breakthrough Therapy Designation from the U.S. Food and Drug Administrati...

Salvat Laboratories announces submission of New Dr…

Salvat Laboratories announced that it has submitted a New Drug Application (NDA) to the FDA for the approval of the first ocular corticosteroid formulated in a nanoemulsi...

Bayer with continued strong performance

The Bayer Group maintained its strong business performance across all three divisions in the third quarter. "Despite rising inflation and global supply chain problems, we...

Vividion Therapeutics names Jenna Goldberg as Chie…

Vividion Therapeutics, Inc., a biopharmaceutical company utilizing novel discovery technologies to unlock high value, traditionally undruggable targets with precision the...

New insights on antibody responses to Omicron vari…

Knowing how well vaccination against one SARS-CoV-2 strain (with or without previous infection) counteracts infection with a different strain is a critical research quest...

Pfizer and BioNTech receive positive CHMP opinion …

Pfizer Inc. (NYSE: PFE) and BioNTech SE (Nasdaq: BNTX) announced a booster dose of their Omicron BA.4/BA.5-adapted bivalent COVID-19 vaccine (COMIRNATY® Original/Omicron ...

Sugar molecules as a target in cancer therapy

Cancer cells use sugar molecules on their surface to disable attacks by the body's immune system. Researchers at the University of Basel now report on how this mechanism ...

COVID vaccination improves effectiveness of cancer…

Patients with nasopharyngeal cancer are often treated with drugs that activate their immune system against the tumor. Until now, it was feared that vaccination against Co...

Making melanoma immortal: Pitt scientists discover…

Scientists at the University of Pittsburgh School of Medicine have discovered the missing puzzle piece in the mystery of how melanoma tumors control their mortality. I...

New drug shows promise for fighting both COVID-19 …

While vaccination can provide life-saving protection against COVID-19, scientists are still searching for ways to treat severe infections, including in people who cannot ...

Study reveals vaccine confidence declined consider…

A new study suggests that, despite the success of the COVID-19 vaccination campaigns, vaccine confidence has declined significantly since the start of the pandemic. Re...

Sanofi and GSK's next-generation COVID-19 booster …

After the European Medicines Agency's Committee for Medicinal Products for Human Use (CHMP) adopted a positive opinion for VidPrevtyn® Beta, the vaccine was approved by t...